Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Mitogen-activated protein kinase 14 | ||
| Ligand | BDBM50375799 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_474267 (CHEMBL935072) | ||
| IC50 | 1.5±n/a nM | ||
| Citation |  Chen, MH; Fitzgerald, P; Singh, SB; O'Neill, EA; Schwartz, CD; Thompson, CM; O'Keefe, SJ; Zaller, DM; Doherty, JB Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors. Bioorg Med Chem Lett18:2222-6 (2008) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Mitogen-activated protein kinase 14 | |||
| Name: | Mitogen-activated protein kinase 14 | ||
| Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 41286.76 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | Q16539 | ||
| Residue: | 360 | ||
| Sequence: |
| ||
| BDBM50375799 | |||
| n/a | |||
| Name | BDBM50375799 | ||
| Synonyms: | CHEMBL270611 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C27H22Cl3N3O3 | ||
| Mol. Mass. | 542.841 | ||
| SMILES | NC1(CC1)C(=O)NCCOc1cc(-c2ccccc2Cl)c2ccc(=O)n(-c3c(Cl)cccc3Cl)c2c1 |(29.39,-28.26,;29.39,-26.72,;30.72,-25.94,;30.73,-27.48,;28.04,-25.99,;26.72,-26.8,;27.99,-24.45,;26.65,-23.69,;25.32,-24.47,;23.98,-23.7,;22.65,-24.48,;22.65,-26.02,;21.32,-26.79,;21.32,-28.33,;19.98,-29.1,;19.98,-30.64,;21.32,-31.41,;22.66,-30.63,;22.65,-29.09,;23.98,-28.32,;19.99,-26.02,;18.67,-26.79,;17.34,-26.02,;17.34,-24.48,;16,-23.72,;18.67,-23.7,;18.67,-22.16,;17.34,-21.39,;16.01,-22.17,;17.34,-19.86,;18.68,-19.08,;20.01,-19.85,;20.01,-21.39,;21.35,-22.16,;20,-24.48,;21.32,-23.72,)| | ||
| Structure | 
| ||